A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
出版年份 2020 全文链接
标题
A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
作者
关键词
-
出版物
Brain Sciences
Volume 10, Issue 3, Pages 176
出版商
MDPI AG
发表日期
2020-03-19
DOI
10.3390/brainsci10030176
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- When to Start Levodopa Therapy for Parkinson’s Disease
- (2019) Susan Bressman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients
- (2019) Martin Klietz et al. DRUGS & AGING
- Polypharmacy in Parkinson’s disease: risks and benefits with little evidence
- (2019) I. Csoti et al. JOURNAL OF NEURAL TRANSMISSION
- Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study
- (2019) Gloria Martí-Andrés et al. Brain Sciences
- Long-term Efficacy of Safinamide on Parkinson’s Disease Chronic Pain
- (2018) Carlo Cattaneo et al. ADVANCES IN THERAPY
- Real life evaluation of safinamide effectiveness in Parkinson’s disease
- (2018) Francesca Mancini et al. NEUROLOGICAL SCIENCES
- Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study
- (2018) Claudio Liguori et al. PARKINSONISM & RELATED DISORDERS
- Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients
- (2018) Claudio Liguori et al. SLEEP MEDICINE
- Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson’s disease
- (2018) Maria Laura Ester Bianchi et al. NEUROLOGICAL SCIENCES
- Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson’s disease
- (2017) Thomas Müller Expert Opinion on Drug Metabolism & Toxicology
- Safinamide for the treatment of Parkinson’s disease
- (2017) Ruth Mary deSouza et al. EXPERT OPINION ON PHARMACOTHERAPY
- Hypersexuality Possibly Associated With Safinamide
- (2017) Félix Javier Jiménez-Jiménez et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effects of Safinamide on Pain in Fluctuating Parkinson’s Disease Patients: A Post-Hoc Analysis
- (2017) Carlo Cattaneo et al. Journal of Parkinsons Disease
- Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson’s Disease
- (2017) Carlo Cattaneo et al. Journal of Parkinsons Disease
- Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Anthony H. V. Schapira et al. JAMA Neurology
- Clinical Pharmacokinetics and Pharmacodynamics of Safinamide
- (2016) Thomas Müller et al. CLINICAL PHARMACOKINETICS
- The safety and efficacy of safinamide mesylate for the treatment of Parkinson’s disease
- (2016) Santiago Perez-Lloret et al. Expert Review of Neurotherapeutics
- Adjuvant therapies for Parkinson’s disease: critical evaluation of safinamide
- (2016) Fabrizio Stocchi et al. Drug Design Development and Therapy
- Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson’s Disease Fluctuating Patients: Post hoc Analysesof Studies 016 and SETTLE
- (2016) Carlo Cattaneo et al. Journal of Parkinsons Disease
- The safety and efficacy of safinamide mesylate for the treatment of Parkinson’s disease
- (2016) Santiago Perez-Lloret et al. Expert Review of Neurotherapeutics
- Safinamide: First Global Approval
- (2015) Emma D. Deeks DRUGS
- Neuroprotection by safinamide in the 6-hydroxydopamine model of Parkinson's disease
- (2015) Mona Sadeghian et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Combination Therapy with Monoamine Oxidase Inhibitors and Other Antidepressants or Stimulants: Strategies for the Management of Treatment-Resistant Depression
- (2015) Samantha J. Thomas et al. PHARMACOTHERAPY
- Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson’s Disease: A Post-Hoc Analysis
- (2015) Carlo Cattaneo et al. Journal of Parkinsons Disease
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)
- (2014) Michel Panisset et al. PHARMACOTHERAPY
- Safinamide for the treatment of Parkinson’s disease
- (2014) Rukmini Mridula Kandadai et al. Expert Review of Clinical Pharmacology
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical Trial
- (2012) A Marquet et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease
- (2012) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease
- (2012) J. J. Ferreira et al. EUROPEAN JOURNAL OF NEUROLOGY
- A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
- (2011) Fabrizio Stocchi et al. MOVEMENT DISORDERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started